UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Immunology, ISSN 1474-1733, 02/2020, Volume 20, Issue 2, pp. 87 - 88
Life Sciences & Biomedicine | Immunology | Science & Technology | RNA, Messenger - immunology | Respiratory Syncytial Virus Vaccines - immunology | Humans | Vaccines - immunology | Recombinant Proteins | Vaccines - therapeutic use | Viral Fusion Proteins - immunology | Influenza Vaccines - immunology | Latent Tuberculosis - drug therapy | Respiratory Syncytial Virus, Human - immunology | Respiratory Syncytial Virus Infections - prevention & control | Influenza Vaccines - therapeutic use | Vaccines, Synthetic | BCG Vaccine - therapeutic use | Drug Development | Tuberculosis Vaccines - immunology | Tuberculosis Vaccines - therapeutic use | Respiratory Syncytial Virus Vaccines - therapeutic use | Adjuvants, Immunologic - therapeutic use | Influenza, Human - prevention & control | Antigens | Adjuvants | Respiratory syncytial virus | Tuberculosis | Vaccines | Influenza | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 07/2020, Volume 38, Issue 35, pp. 5564 - 5568
Antimalarial | Gender | COVID 19 | Age | BCG | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Coronavirus Infections - prevention & control | Hydroxychloroquine - therapeutic use | Humans | Pandemics - prevention & control | Geographic Mapping | Infant | Male | Coronavirus Infections - mortality | COVID-19 | Coronavirus Infections - transmission | Pneumonia, Viral - transmission | Chloroquine - pharmacology | Disease Susceptibility - immunology | Aging | Female | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Chemoprevention | Chloroquine - therapeutic use | Sex Characteristics | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Internationality | Pneumonia, Viral - prevention & control | BCG Vaccine - immunology | Hydroxychloroquine - pharmacology | Pneumonia, Viral - mortality | Prevention | Epidemics | Malaria | Female-male relations | Mortality | BCG vaccines | Vaccines | Health aspects | Pneumonia | Pandemics | Chloroquine | Viral diseases | Cytotoxicity | Viruses | Infections | Middle East respiratory syndrome | Measles | Immune system | Vector-borne diseases | Pathogens | Bacterial infections | Cytokines | Severe acute respiratory syndrome | Coronaviruses | Metabolism | Severe acute respiratory syndrome coronavirus 2 | Disease prevention | Infectious diseases | Hydroxychloroquine | Tuberculosis | Disease transmission | Lungs | Respiratory diseases | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 498 - 509
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Malaria, Falciparum - prevention & control | Double-Blind Method | Humans | Fluorenes - therapeutic use | Artemisinins - administration & dosage | Male | Antimalarials - therapeutic use | Plasmodium falciparum - immunology | Ethanolamines - administration & dosage | Artemisinins - therapeutic use | Vaccination - methods | Antimalarials - administration & dosage | Mali | Adolescent | Adult | Artemether | Ethanolamines - therapeutic use | Female | Fluorenes - administration & dosage | Immunization Schedule | Lumefantrine | Plasmodium falciparum | Medical research | Malaria | Parasitic diseases | Clinical trials | Medicine, Experimental | Product development | Adults | Vaccines | Analysis | Vaccination | Biometrics | Asymptotic properties | Toxicity | Antibodies | Bites | Homology | Infections | Parasites | Developing countries--LDCs | Antibody response | Incidence | Hepatitis | Towns | Alignment | Cryopreservation | Syphilis | Human immunodeficiency virus--HIV | Attenuation | Libraries | Masking | Safety | Drug dosages | Age | Circumsporozoite protein | EKG | Antigens | Hum | Immunological memory | Effectiveness | Review boards | Abnormalities | Hypersensitivity | BCG | Contraception | Exposure | Vectors | Appendix | Pregnancy | Disease transmission | Infectious diseases | Immunogenicity | Added value | Differentiation | Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 01/2013, Volume 104, Issue 1, pp. 22 - 27
Life Sciences & Biomedicine | Oncology | Science & Technology | Mycobacterium bovis - immunology | Humans | Vaccines, Synthetic - therapeutic use | Vaccines, Synthetic - immunology | Urothelium - pathology | Immunotherapy - adverse effects | Vaccines, Synthetic - adverse effects | BCG Vaccine - adverse effects | Urinary Bladder Neoplasms - therapy | BCG Vaccine - immunology | Urinary Bladder Neoplasms - immunology | Administration, Intravesical | BCG Vaccine - therapeutic use | Liposomes | Urothelium - microbiology | Cancer vaccines | Care and treatment | Drug therapy | Bladder cancer | Immunotherapy | Cancer | Index Medicus | Review
Journal Article
Nature medicine, ISSN 1078-8956, 2013, Volume 19, Issue 4, pp. 410 - 411
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Viral Vaccines - therapeutic use | Tuberculosis Vaccines - adverse effects | Humans | Infant | Clinical Trials as Topic | BCG Vaccine - therapeutic use | Tuberculosis Vaccines - therapeutic use | Tuberculosis, Pulmonary - prevention & control | Tuberculosis vaccines | Quality management | Proteins | Clinical trials | Tuberculosis | Immunology | Vaccines | Index Medicus
Journal Article
Paediatric respiratory reviews, ISSN 1526-0542, 2015, Volume 22, pp. 23 - 30
Pediatrics | Pulmonary/Respiratory | Developing countries | Pneumonia | Vaccines | Children | Respiratory System | Life Sciences & Biomedicine | Science & Technology | Haemophilus Vaccines - therapeutic use | Measles Vaccine - therapeutic use | Humans | Pneumococcal Vaccines - therapeutic use | Pneumonia - prevention & control | Child, Preschool | Haemophilus Infections - prevention & control | Infant | Vaccines - therapeutic use | Tuberculosis, Pulmonary - prevention & control | Pertussis Vaccine - therapeutic use | Whooping Cough - prevention & control | Influenza Vaccines - therapeutic use | Measles - prevention & control | Pneumonia, Pneumococcal - prevention & control | Developing Countries | BCG Vaccine - therapeutic use | Child | Influenza, Human - prevention & control | Prevention | Respiratory tract infections | Vaccination | Respiratory tract diseases | Diseases | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 26, pp. 2911 - 2914
Allergy and Immunology | Vaccine | Tuberculosis | BCG | Latency | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Mass Vaccination | Animals | Mycobacterium tuberculosis | Humans | Tuberculosis - prevention & control | Biomedical Research - trends | Clinical Trials as Topic | BCG Vaccine - therapeutic use | Tuberculosis Vaccines - therapeutic use | Medicine, Experimental | Medical research | Tuberculosis vaccines | Industrial research | Vaccination | Drug resistance in microorganisms | Disease transmission | Analysis | Communicable diseases | Development and progression | Infants | Antigens | Global health | Candidates | Young adults | Research & development--R&D | Funding | Mortality | Clinical trials | Infections | Vaccines | Drug resistance | Prevention | Proteins | Adenoviruses | Influenza | Teenagers | Portfolio management | Immune system | Index Medicus
Journal Article
Pediatrics (Evanston), ISSN 0031-4005, 08/2014, Volume 134, Issue 2, pp. e362 - e372
Proteobacteria | Bifidobacterium | Antibody | Polio | Vaccine | Intestinal | Hepatitis | Bangladesh | Microbiota | Tuberculosis | Actinobacteria | T lymphocyte | Tetanus | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Poliovirus Vaccine, Oral - immunology | Humans | Infant | Male | Vaccines - therapeutic use | Bifidobacterium - isolation & purification | Dysbiosis - immunology | Feces - microbiology | Enterobacteriaceae - immunology | Female | Actinobacteria - isolation & purification | Nutritional Status | Pseudomonas - immunology | RNA, Ribosomal, 16S | DNA, Bacterial - isolation & purification | Microbiota - immunology | Tetanus Toxoid - therapeutic use | Vaccines - immunology | Sequence Analysis, DNA | Hepatitis B Vaccines - therapeutic use | BCG Vaccine - immunology | T-Lymphocytes - immunology | Thymus Gland - immunology | Hepatitis B Vaccines - immunology | Microbiological Techniques | BCG Vaccine - therapeutic use | Tetanus Toxoid - immunology | Infants | Research | Vaccines | Microbiota (Symbiotic organisms) | Health aspects | Polymerase chain reaction | Babies | Bacteria | Immunoglobulins | Lymphocytes | Index Medicus | Abridged Index Medicus | microbiota | antibody | tuberculosis | hepatitis | polio | intestinal | vaccine | tetanus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 2014, Volume 14, Issue S1, pp. S2 - S2
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Tuberculosis - epidemiology | Tuberculosis - immunology | Immunization, Secondary | Adjuvants, Immunologic | Humans | Tuberculosis - prevention & control | BCG Vaccine - immunology | Tuberculosis Vaccines - immunology | Tuberculosis Vaccines - therapeutic use | Pediatrics | Health sciences | Tuberculosis | Disease | Cytokines | Human immunodeficiency virus--HIV | Colleges & universities | Clinical trials | Interferon | Vaccines | Tumors | Index Medicus
Journal Article